134 related articles for article (PubMed ID: 30310320)
1. Identification of WDR12 as a novel oncogene involved in hepatocellular carcinoma propagation.
Yin Y; Zhou L; Zhan R; Zhang Q; Li M
Cancer Manag Res; 2018; 10():3985-3993. PubMed ID: 30310320
[TBL] [Abstract][Full Text] [Related]
2. WDR12/RAC1 axis promoted proliferation and anti-apoptosis in colorectal cancer cells.
Wen S; Huang X; Xiong L; Zeng H; Wu S; An K; Bai J; Zhou Z; Yin T
Mol Cell Biochem; 2024 Feb; ():. PubMed ID: 38341833
[TBL] [Abstract][Full Text] [Related]
3. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
[TBL] [Abstract][Full Text] [Related]
4. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
5. Alkaline ceramidase 3 promotes growth of hepatocellular carcinoma cells via regulating S1P/S1PR2/PI3K/AKT signaling.
Yin Y; Xu M; Gao J; Li M
Pathol Res Pract; 2018 Sep; 214(9):1381-1387. PubMed ID: 30097213
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Ribosome Biogenesis by Targeting WD Repeat Domain 12 (WDR12) Inhibits Glioma Stem-Like Cell Growth.
Mi L; Qi Q; Ran H; Chen L; Li D; Xiao D; Wu J; Cai Y; Zhang S; Li Y; Li B; Xie J; Huang H; Li T; Zhou T; Li A; Qi J; Li F; Man J
Front Oncol; 2021; 11():751792. PubMed ID: 34868955
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma.
Zhu Z; Zhang Y; Huang C; Tang Y; Sun C; Ju W; He X
Cancer Manag Res; 2018; 10():5559-5572. PubMed ID: 30519104
[TBL] [Abstract][Full Text] [Related]
8. Integrative genomic analyses identify WDR12 as a novel oncogene involved in glioblastoma.
Li JL; Chen C; Chen W; Zhao LF; Xu XK; Li Y; Yuan HY; Lin JR; Pan JP; Jin BL; Li FC
J Cell Physiol; 2020 Oct; 235(10):7344-7355. PubMed ID: 32180229
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
10. Autophagy-Related Gene WD Repeat Domain 45B Promotes Tumor Proliferation and Migration of Hepatocellular Carcinoma through the Akt/mTOR Signaling Pathway.
Li J; Chen L; Pang J; Yang C; Xie W; Shen G; Chen H; Li X; Xiao SY; Li Y
Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900050
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the Expression of
Mu R; Chang M; Feng C; Cui Y; Li T; Liu C; Wang Y; Guo X
Curr Genomics; 2024 Feb; 25(1):2-11. PubMed ID: 38544826
[TBL] [Abstract][Full Text] [Related]
12. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
13. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors.
Eid RA; Eldeen MA; Soltan MA; Al-Shraim M; Aldehri M; Alqahtani LS; Alsharif G; Albogami S; Jafri I; Fayad E; Park MN; Bibi S; Behairy MY; Kim B; Zaki MSA
Front Genet; 2022; 13():1008502. PubMed ID: 36726716
[No Abstract] [Full Text] [Related]
15. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
16. Targeted inhibition of ACK1 can inhibit the proliferation of hepatocellular carcinoma cells through the PTEN/AKT/mTOR pathway.
Wang B; Song K; Chen L; Su H; Gao L; Liu J; Huang A
Cell Biochem Funct; 2020 Jul; 38(5):642-650. PubMed ID: 32162707
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of the ribosome biogenesis factors PES, BOP1, and WDR12 (PeBoW), and mechanisms of defective cell growth and proliferation caused by PeBoW deficiency in Arabidopsis.
Ahn CS; Cho HK; Lee DH; Sim HJ; Kim SG; Pai HS
J Exp Bot; 2016 Sep; 67(17):5217-32. PubMed ID: 27440937
[TBL] [Abstract][Full Text] [Related]
18. TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma.
Wang F; Zhang B; Xu X; Zhu L; Zhu X
Pathol Res Pract; 2020 Apr; 216(4):152850. PubMed ID: 32046874
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA
Gong X; Zhu Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
[No Abstract] [Full Text] [Related]
20. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
